Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX1EZJ
|
||||
| Drug Name |
[(S)-1-((2S,3S)-2-Butoxy-4-oxo-azetidin-3-ylcarbamoyl)-2-phenyl-ethyl]-carbamic acid benzyl ester
|
||||
| Synonyms |
CHEMBL30969
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C24H29N3O5
|
||||
| Canonical SMILES |
CCCCO[C@@H]1NC(=O)[C@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)OCc3ccccc3
|
||||
| InChI |
InChI=1S/C24H29N3O5/c1-2-3-14-31-23-20(22(29)27-23)26-21(28)19(15-17-10-6-4-7-11-17)25-24(30)32-16-18-12-8-5-9-13-18/h4-13,19-20,23H,2-3,14-16H2,1H3,(H,25,30)(H,26,28)(H,27,29)/t19-,20+,23-/m0/s1
|
||||
| InChIKey |
GFBNAICZWORTRP-MZKRTTBSSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.